Excess body weight is associated with numerous reproductive disorders in both women and men, and even modest weight reduction of 510% can lead to significant improvements in fertility outcomes
In addition to suppressing appetite, semaglutide also regulates blood sugar levels
, June 26, 2026 ClinicalTrials.gov, Provide Pre-approval Expanded Access of LY3437943 , accessed June 29, 2026 National Cancer Institute, Definition of phase III clinical trial - NCI Dictionary of Cancer Terms , accessed June 26, 2026 ClinicalTrials.gov, NCT06859268 | A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity , accessed June 26, 2026 ClinicalTrials.gov, NCT06383390 The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes) , accessed June 28, 2026 ClinicalTrials.gov, A Study of Retatrutide (LY3437943) in Participants With Obesity or Overweight (TRIUMPH-8) , accessed June 29, 2026 U.S
That, together with the Cleveland Clinic studies showing cardiovascular outcome benefits from bariatric surgery, prompted Dr
& Tang, S
GLP-1s may be risky for older adults